Richard B. Lipton, Robert Croop, David A. Stock, Jennifer Madonia, Micaela Forshaw, Meghan Lovegren, Linda Mosher, Vladimir Coric, Peter J Goadsby: Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial. In: Lancet Neurology. 2023, Band 22, Nummer 3, S. 209–217 doi:10.1016/S1474-4422(22)00517-8.